Editors:
- Provides evidence-based guidance on diagnosis, treatment, and prognosis
- Explains the fundamental principles underlying the available diagnostic and treatment approaches
- Covers the etiology and management of all the common types of urologic cancer plus rare malignancies
- Includes supplementary material: sn.pub/extras
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (61 entries)
-
Front Matter
-
Prostate Cancer
-
Front Matter
-
-
Bladder Cancer
-
Front Matter
-
About this book
This comprehensive and timely textbook covers all aspects of the evidence-based management of genitourinary cancers and explains the fundamental principles underlying the available diagnostic and treatment approaches, including chemotherapy, radiotherapy, immunotherapy, and surgery. For each type of cancer – prostate, bladder, renal, testicular, and penile, plus rare urologic malignancies – clinical presentation, diagnosis, and treatment strategies are described in detail and information is provided on etiology, epidemiology, risk factors, and pathology, including TNM classification. Careful attention is also devoted to the complications that may be encountered when treating urologic malignancies and to the management of these complications. The text is complemented by the inclusion of numerous high-definition photographs and illustrations. Urologic Oncology will be a valuable reference and source of guidance for all oncologists, urologists and practitioners in related disciplines who treat patients with urologic cancers.
Editors and Affiliations
-
Department of Urology, University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany
Axel S. Merseburger
-
Department of Urology, Caritas-St. Josef Medical Center, University of Regensburg, Regensburg, Germany
Maximilian Burger
About the editors
Professor Merseburger is a member of various uro-oncology organisations and serves as an advisor for the European Association of Urology (EAU) Guideline Group for Renal Cancer and was the Chairman of the EAU Guideline Group for Lasers and Technologies. He acts as reviewer and editorial board member for several urology and oncology indexed journals and is associate editor of the World Journal of Urology and editor in Chief of European Oncology & Haematology Journal.
Professor Merseburger’s research activity encompasses both molecular and clinical aspects of uro-oncology, with specific interest in biomarkers and prognostic factors for prostate cancer, renal cell carcinoma and transitional cell carcinoma. He has authored and co-authored more than 200 peer-reviewed articles and he is the principal investigator in multiple phase II and III clinical trials.
Prof. Dr. med. Maximilian Burger, F.E.B.U.,MD, is Professor of Urology and Chairman of the Department of Urology, Caritas-St. Josef Medical Center, University of Regensburg, Germany. He was born in Munich, Germany in 1974 and attended the Medical Schools of the Universities of Ulm and Regensburg and Tulane University, New Orleans, Louisiana, USA graduating in 2000. He underwent urology training at the departments of the Universities of Mainz and Regensburg and was board certified in 2005. In 2007 he was appointed Assistant Professor ofUrology by the University of Regensburg. From 2011 to 2013 he was appointed Assistant Professor of Urology by the Julius-Maximilians University of Würzburg (Chairman Prof. Dr. Riedmiller) serving as Deputy Chairman (Leitender Oberarzt). He was appointed Professor of Urology and Chairman of the department in Regensburg in 2013. His main clinical and academical focus is surgical and medical uro-oncology. He has authored and coauthored numerous papers mainly on bladder and prostate cancer. He is a member of the national German bladder cancer guideline panel (S3) since 2012 and a member of the non-muscle invasive bladder cancer guideline panel of the European Association of Urology (EAU) since 2012 serving as its Vice-Chairman. In 2014, he was elected to the board of the the German Association of Urology (DGU).
Bibliographic Information
Book Title: Urologic Oncology
Editors: Axel S. Merseburger, Maximilian Burger
DOI: https://doi.org/10.1007/978-3-319-42623-5
Publisher: Springer Cham
eBook Packages: Medicine, Reference Module Medicine
Copyright Information: Springer Nature Switzerland AG 2019
Hardcover ISBN: 978-3-319-42622-8Published: 21 August 2019
eBook ISBN: 978-3-319-42623-5Published: 31 July 2019
Edition Number: 1
Number of Pages: XXVII, 870
Number of Illustrations: 19 b/w illustrations, 129 illustrations in colour
Topics: Oncology, Urology, Radiotherapy, Surgery, Pathology